Repsly Announces New Retail Technology Partnership with Curaleaf

Repsly a best-in-class retail technology platform, today announced it has entered into a technology partnership agreement with Curaleaf (CSE: CURA OTCQX: CURLF), a leading international provider of consumer products in cannabis. This agreement will support Curaleaf's wholesale operations across the US by providing CRM solutions, retail execution support, and business analytics and insights to the Curaleaf teams.

With 125 dispensaries in 23 U.S. states, Curaleaf is one of the largest vertically integrated cannabis companies. Curaleaf chose Repsly after realizing a need to enhance their technology stack in support of their quickly expanding go-to-market needs within North America .

"With Repsly's powerful operational platform and their Insights Dashboard business intelligence solution, we'll be able to assess our wholesale execution plans with real-time and trended data on sales performance, promotion execution and more. These data-driven insights will allow our team to learn and pivot on a dime as feedback comes in from their field," said Patrick Larkin , SVP of Sales at Curaleaf.

"Our team at Repsly is obsessed with helping our customers win by executing perfectly at all aspects of retail, every day," said Matthew Brogie , CEO at Repsly. "Knowing that we have the opportunity to help Curaleaf navigate competitively in one of the fastest growing consumer industries, and that we can support Curaleaf and their portfolio of brands in their next generation plans is extremely energizing for our team! We're looking forward to rolling up our sleeves and working hard to demonstrate that Repsly is the right partner to support Curaleaf in this amazing growth journey."

Curaleaf will begin to roll out the Repsly platform in February 2022 .

About Repsly
Repsly, Inc. is a retail execution software that empowers CPG teams to make data-driven insights and achieve peak performance in the field. Repsly helps global brands like Kraft Heinz, Adidas, L'Oreal, Spindrift, Beyond Meat, Mattel, and AB InBev control compliance at the brand level, improve coverage at the territory level, and execute at the store level. Repsly is the only retail execution solution to connect store-level activities with their impact on sales. Headquartered in Boston, MA with offices globally, Repsly works with over 800 brands in 80 countries around the world.

About Curaleaf
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States , Curaleaf currently operates in 23 states with 125 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Media enquiries to:
Cait Will ( cait.will@repsly.com )
Stephanie Pojatina ( stephanie.pojatina@repsly.com )

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/repsly-announces-new-retail-technology-partnership-with-curaleaf-301473778.html

SOURCE Repsly Inc.

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/February2022/02/c9108.html

News Provided by Canada Newswire via QuoteMedia

CURA:CNX,CURLF
The Conversation (0)
Gavel resting on cannabis leaves.

Cannabis Crossroads: Record US Demand Meets Federal Gridlock

The US cannabis industry is at a turning point. State-level legalization and retail growth continue to accelerate, but federal policy remains stalled, leaving businesses navigating both opportunity and uncertainty. Record consumer demand is driving sales, yet outdated regulations, restrictive... Keep Reading...
Cannabis leaf.

10 Biggest Cannabis Stocks in the US and Canada in 2025

After initial optimism for rescheduling in the US, the cannabis market has faced challenges in 2025. Despite signs of support from US President Donald Trump and members of his administration, regulatory uncertainty persists in the US. Companies are shifting focus to match changes in consumer... Keep Reading...
Field of cannabis plants under bright sunlight.

Cannabis Market Update: H1 2025 in Review

The first half of 2025 played out differently than many cannabis market participants expected. Heading into the year, there was optimism that rescheduling in the US would reduce or eliminate challenges, but the industry continued to grapple with persistent federal regulatory uncertainty,... Keep Reading...
Closeup of lush green cannabis leaves.

Thailand Reverses Course on Cannabis, Moves to Recriminalize Amid Political Fallout

Thailand’s groundbreaking experiment with cannabis decriminalization is rapidly unraveling, with the government formally moving to reclassify the plant as a narcotic and ban recreational sales.The decision has sent shockwaves through an industry once projected to be worth over US$1 billion.The... Keep Reading...
Cannabis leaf over map of Australia.

A State-by-State Guide to Cannabis in Australia

Australia federally legalised medicinal cannabis in 2016, and Australia's cannabis market has seen major growth since then.Medical cannabis approvals were up by 120 percent in the first half of 2023 compared to the same period in 2022. Statista forecasts that Australian cannabis revenue will... Keep Reading...
Cannabis leaf on road marked with "2025," with sunlight in the background.

New Cannabis Consumption Trends, Regulatory Shifts Seen Driving Market in 2025

Understanding trends in the cannabis industry is paramount for investors eyeing a market with steady growth potential, but the landscape is complex as products and regulations continue to evolve. Consumption habits are changing as edibles, vaping and THC beverages gain traction, especially among... Keep Reading...

Latest Press Releases

Related News